TALPROXAD Trademark

Trademark Overview


On Thursday, December 8, 2022, a trademark application was filed for TALPROXAD with the United States Patent and Trademark Office. The USPTO has given the TALPROXAD trademark a serial number of 97708465. The federal status of this trademark filing is REGISTERED as of Tuesday, January 9, 2024. This trademark is owned by Glaxo Group Limited. The TALPROXAD trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
talproxad

General Information


Serial Number97708465
Word MarkTALPROXAD
Filing DateThursday, December 8, 2022
Status700 - REGISTERED
Status DateTuesday, January 9, 2024
Registration Number7267507
Registration DateTuesday, January 9, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2023

Trademark Statements


Goods and ServicesVaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 5, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Trademark Events


Event DateEvent Description
Tuesday, January 9, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 9, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 24, 2023PUBLISHED FOR OPPOSITION
Wednesday, October 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 14, 2023ASSIGNED TO EXAMINER
Wednesday, July 12, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 12, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 12, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 5, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 12, 2022NEW APPLICATION ENTERED